// App-Quantinova.ai

592 : Two Novel Diagnostic Biomarkers of Cartilage Degradation and Connective Tissue Inflammation Are Predictive of Disease Progression in Ankylosing Spondylitis

Researchers

Presenter

  • Anne C. Bay-Jensen

Principal Investigators

  • Stephanie Wichuk

  • Inger Byrjalsen

  • Zheng Zhao

  • Robert GW Lambert

  • Morten Asser Karsdal

  • Walter P. Maksymowych

Medical Centers

  • Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China

  • Department of Surgery, University of Alberta, Edmonton, AB, Canada

  • Hepatology, University of Alberta, Edmonton, Alberta, Canada

  • Hepatology, University of Alberta, Edmonton, Alberta, Canada

Locations

  • Canada

  • China

Companies

  • Nordic Bioscience A/

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim